Inari Medical, Inc.
NASDAQ:NARI
44.38 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 145.82 | 143.194 | 132.094 | 126.366 | 119.005 | 116.167 | 107.771 | 96.204 | 92.744 | 86.752 | 83.218 | 72.916 | 63.453 | 57.397 | 48.61 | 38.715 | 25.392 | 26.953 | 19.887 | 14.225 | 10.072 | 6.945 |
| Cost of Revenue
| 23.542 | 18.893 | 18.139 | 14.477 | 13.844 | 13.741 | 13.128 | 11.064 | 10.347 | 9.967 | 8.28 | 7.04 | 4.814 | 4.623 | 3.686 | 3.228 | 3.487 | 2.706 | 2.138 | 1.51 | 1.331 | 0.931 |
| Gross Profit
| 122.278 | 124.301 | 113.955 | 111.889 | 105.161 | 102.426 | 94.643 | 85.14 | 82.397 | 76.785 | 74.938 | 65.876 | 58.639 | 52.774 | 44.924 | 35.487 | 21.905 | 24.247 | 17.748 | 12.715 | 8.741 | 6.014 |
| Gross Profit Ratio
| 0.839 | 0.868 | 0.863 | 0.885 | 0.884 | 0.882 | 0.878 | 0.885 | 0.888 | 0.885 | 0.901 | 0.903 | 0.924 | 0.919 | 0.924 | 0.917 | 0.863 | 0.9 | 0.892 | 0.894 | 0.868 | 0.866 |
| Reseach & Development Expenses
| 24.905 | 26.88 | 22.892 | 21.492 | 21.085 | 22.064 | 20.412 | 19.105 | 18.569 | 16.135 | 18.726 | 12.499 | 11.63 | 8.163 | 6.535 | 5.217 | 3.628 | 3.018 | 2.709 | 1.722 | 1.58 | 1.209 |
| General & Administrative Expenses
| 0 | 0 | 91.462 | 0 | 0 | 0 | 79.165 | 0 | 0 | 0 | 54.122 | 0 | 0 | 0 | 31.393 | 22.974 | 18.88 | 16.393 | 13.844 | 10.07 | 7.797 | 5.426 |
| Selling & Marketing Expenses
| 0 | 0 | 1.2 | 0 | 0 | 0 | 0.957 | 0 | 0 | 0 | 0.344 | 0 | 0 | 0 | 0.116 | 0.106 | 0.074 | 0.037 | 0.025 | 0.03 | 0.006 | 0.028 |
| SG&A
| 113.053 | 103.055 | 92.662 | 88.284 | 85.586 | 85.7 | 80.122 | 75.833 | 73.156 | 63.732 | 54.466 | 56.104 | 42.897 | 36.898 | 31.393 | 23.08 | 18.88 | 16.393 | 13.869 | 10.1 | 7.803 | 5.426 |
| Other Expenses
| 0.023 | -0.023 | 3.478 | -0.682 | 0.026 | 0.039 | 0.187 | -0.059 | 0.252 | -0.024 | -0.014 | 0.03 | 0.007 | -0.041 | -0.011 | -0.651 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 137.958 | 132.396 | 115.554 | 109.776 | 106.671 | 107.764 | 100.534 | 94.938 | 91.725 | 79.867 | 73.192 | 68.603 | 54.527 | 45.061 | 37.928 | 28.297 | 22.508 | 19.411 | 16.578 | 11.822 | 9.383 | 6.635 |
| Operating Income
| -15.68 | -17.177 | -1.599 | 2.113 | -1.51 | -1.154 | -5.891 | -9.798 | -9.328 | -3.082 | 1.746 | -2.727 | 4.112 | 7.713 | 6.996 | 7.19 | -0.603 | 4.836 | 1.17 | 0.893 | -0.642 | -0.621 |
| Operating Income Ratio
| -0.108 | -0.12 | -0.012 | 0.017 | -0.013 | -0.01 | -0.055 | -0.102 | -0.101 | -0.036 | 0.021 | -0.037 | 0.065 | 0.134 | 0.144 | 0.186 | -0.024 | 0.179 | 0.059 | 0.063 | -0.064 | -0.089 |
| Total Other Income Expenses Net
| -5.742 | -9.105 | -1.577 | -0.682 | 0.026 | -0.04 | 1.083 | 0.485 | 0.393 | -0.047 | -0.014 | 0.03 | 0.007 | -0.041 | -0.011 | -0.651 | -2.884 | -0.433 | -0.6 | -0.32 | -0.118 | -0.124 |
| Income Before Tax
| -21.422 | -16.087 | -3.176 | 5.59 | 3.024 | -1.194 | -4.808 | -9.313 | -8.935 | -3.129 | 1.681 | -2.743 | 4.08 | 7.667 | 6.985 | 6.496 | -3.804 | 4.112 | 0.355 | 0.366 | -0.965 | -0.948 |
| Income Before Tax Ratio
| -0.147 | -0.112 | -0.024 | 0.044 | 0.025 | -0.01 | -0.045 | -0.097 | -0.096 | -0.036 | 0.02 | -0.038 | 0.064 | 0.134 | 0.144 | 0.168 | -0.15 | 0.153 | 0.018 | 0.026 | -0.096 | -0.137 |
| Income Tax Expense
| 9.926 | 8.115 | 1.491 | 2.428 | 0.939 | 1.024 | 0.99 | 0.84 | 1.252 | 0.047 | 0.574 | 0.061 | 0.012 | 0.198 | -0.39 | -0.758 | 0.463 | 0.346 | 0.033 | 0.226 | 0.229 | 0.227 |
| Net Income
| -31.348 | -24.202 | -4.667 | 3.162 | 2.085 | -2.218 | -5.798 | -10.153 | -10.187 | -3.176 | 1.107 | -2.804 | 4.068 | 7.469 | 6.985 | 6.496 | -3.804 | 4.112 | 0.355 | 0.366 | -0.965 | -0.948 |
| Net Income Ratio
| -0.215 | -0.169 | -0.035 | 0.025 | 0.018 | -0.019 | -0.054 | -0.106 | -0.11 | -0.037 | 0.013 | -0.038 | 0.064 | 0.13 | 0.144 | 0.168 | -0.15 | 0.153 | 0.018 | 0.026 | -0.096 | -0.137 |
| EPS
| -0.54 | -0.42 | -0.081 | 0.06 | 0.04 | -0.041 | -0.11 | -0.19 | -0.19 | -0.062 | 0.02 | -0.056 | 0.08 | 0.15 | 0.14 | 0.13 | -0.16 | 0.089 | 0.009 | 0.01 | -0.025 | -0.025 |
| EPS Diluted
| -0.54 | -0.42 | -0.081 | 0.05 | 0.04 | -0.041 | -0.11 | -0.19 | -0.19 | -0.062 | 0.02 | -0.056 | 0.07 | 0.13 | 0.13 | 0.12 | -0.16 | 0.089 | 0.008 | 0.008 | -0.022 | -0.021 |
| EBITDA
| -10.943 | -2.311 | 0.561 | 7.805 | 5.208 | 1.819 | -2.844 | -7.495 | -7.044 | -1.389 | 1.756 | -1.67 | 5.013 | 8.526 | 7.06 | 6.747 | -0.158 | 5.164 | 1.218 | 1.068 | -0.502 | -0.486 |
| EBITDA Ratio
| -0.075 | -0.016 | 0.004 | 0.062 | 0.044 | 0.016 | -0.026 | -0.078 | -0.076 | -0.016 | 0.021 | -0.023 | 0.079 | 0.149 | 0.145 | 0.174 | -0.006 | 0.192 | 0.061 | 0.075 | -0.05 | -0.07 |